SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CTKB

Cytek Biosciences, Inc. (NASDAQ:CTKB)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$6.12-$0.20 (-3.16%)
 
Market cap
$800M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 23, 2021
Market Cap$800.40M+4.1%
Revenue (ttm)$207.65M+5.5%
Net Income-$81.20M-533.4%
EPS-$0.63-504.0%
Shares Out130.78M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,765,925
Open$6.22
Previous Close$6.32
Day's Range$5.99 - $6.39
52-Week Range$3.31 - $6.39
Beta1.14
AnalystsBuy
Price Target$5.50(-10.13%)
Earnings DateFeb 25, 2027

About CTKB

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.

Address
47215 Lakeview Boulevard, Fremont, CA, 94538-6407, US
Market Cap
800 million
Employees
700
Industrial Classification
Medical - Devices

Analyst consensus

Moderate Buy
1 Buy0 Hold0 Sell

1 firm rating CTKB in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From CTKB’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-3.16%
5 Days
+5.88%
1 Month
+11.27%
6 Months
+54.55%
1 Year
+4.08%

$CTKB stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CTKB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CTKB's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CTKB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CTKB Revenue by Segment or Geography

$77.74MTotal
Direct sales channel$42.30M54.42%
Academia and government$24.51M31.53%
Distributor channel$10.93M14.05%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CTKB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CTKB from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CTKB

IWMiShares Russell 2000 ETF$20.17M
VTIVanguard Morningstar Total Stock Market ETF$17.03M
VXFVanguard Extended Market ETF$7.73M
IWNiShares Russell 2000 Value ETF$7.21M
IBBiShares Biotechnology ETF$5.84M
DFASDimensional - US Small Cap ETF$5.27M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CTKB’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
77
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

VFLQVanguard U.S. Liquidity Factor ETF0.43%
FSEVFidelity Enhanced Small Cap Value ETF0.31%
EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF0.25%
RUSCRussell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETF0.19%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.09%
SLYSPDR S&P 600 Small Cap ETF0.08%
FESMFidelity Enhanced Small Cap ETF0.07%
VTWVVanguard Russell 2000 Value ETF0.05%
IWNiShares Russell 2000 Value ETF0.05%
IBBiShares Biotechnology ETF0.05%
VHTVanguard Health Care ETF0.01%

Weight is the stock’s share of each fund’s holdings.